Pathos AI

IL - Chicago

Biotechnology

Focus: In-Licensing Clinical Drugs

Pathos AI is a life sciences company focused on In-Licensing Clinical Drugs.

Oncology

Funding Stage

SERIES A

Open Jobs

Pipeline & Clinical Trials

Pocenbrodib

Phase 1/2

Clinical Trials (1)

NCT06785636Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617

Phase 1/2

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2022

Portfolio: 1 clinical trial

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles